MOREPENLAB Morepen Laboratories Ltd Product Launches Announcement 2025 - New Drug Launch Morepen Laboratories Ltd has received clearance from CDSCO to conduct Bioequivalence studies for Resmetirom, a new drug for fatty liver disease, marking a significant step toward its global launch on April 29, 2025..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Morepen Laboratories Ltd